Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant

NCT05899829 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough
Healthy

Interventions

DRUG: Camlipixant
DRUG: Rabeprazole
DRUG: Rifampin

Sponsor

Bellus Health Inc. - a GSK company